Table 2.
Baseline characteristics and comparison of clinical factors between responders and nonresponders
| Clinicopathologic parameters | Responders (n = 9) | Nonresponders (n = 211) | p value1 |
|---|---|---|---|
| Age | (-1) | 0.7384 | |
| <55 years | 3 | 88 | |
| ≥55 years | 6 | 122 | |
| Gender | (-1) | 0.4148 | |
| Male | 6 | 165 | |
| Female | 3 | 45 | |
| HBV | (-1) | 0.3627 | |
| Absent | 0 | 37 | |
| Present | 9 | 173 | |
| HCV | (-2) | 1 | |
| Absent | 9 | 200 | |
| Present | 0 | 9 | |
| Tumor TNM stage (AJCC | 7th ed.) | (-6) | 0.7607 |
| I | 0 | 0 | |
| II | 0 | 10 | |
| III | 2 | 29 | |
| IV | 7 | 166 | |
| BCLC stage | (-2) | 0.4223 | |
| A | 0 | 3 | |
| B | 2 | 23 | |
| C | 7 | 181 | |
| D | 0 | 2 | |
| AFP | (-14) | 0.7363 | |
| <100 ng/mL | 5 | 91 | |
| ≥100 ng/mL | 4 | 106 | |
| Tumor response | |||
| Complete response | 1 | 0 | |
| Partial response | 8 | 0 | |
| Stable disease | 0 | 68 | |
| Progressive disease | 0 | 143 |
HBV, hepatitis B virus; HCV, hepatitis C virus; TNM, Tumor, Node, and Metastasis classification; AJCC, American Joint Committee on Cancer; BCLC, Barcelona Clinic Liver Cancer; AFP, α-fetoprotein. 1 p values were calculated using Fisher's exact test.